Showing results (1171-1180 of 1,373) with videos related to

Sort By:
Pageof 138
Therapeutic Advances in Neurological Disorders|August 4, 2025
Clinical and mechanistic effects of cladribine in relapsing multiple sclerosis: 2-year results from the MAGNIFY-MS StudyKlaus Schmierer, Heinz Wiendl, Frederik Barkhof, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2005
Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study groupMichel Marty, Francesco Cognetti, Dominique Maraninchi, et al.
Annals of Clinical and Translational Neurology|July 1, 2015
Expanded CD8 T-cell sharing between periphery and CNS in multiple sclerosisMarion Salou, Alexandra Garcia, Laure Michel, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|December 19, 2019
Semi-automatic measurement of intracranial hemorrhage growth on non-contrast CTKevin J Chung, Hulin Kuang, Alyssa Federico, et al.
The Review of Scientific Instruments|September 7, 2013
Measuring fast electron spectra and laser absorption in relativistic laser-solid interactions using differential bremsstrahlung photon detectorsR H H Scott, E L Clark, F Pérez, et al.
Rheumatology (Oxford, England)|August 4, 2023
Evolution of monoclonal gammopathy of undetermined significance in patients treated with JAK inhibitors for rheumatic diseases: data from the MAJIK-SFR registryDéborah Faganello, Anne Bertrand, Pauline Meunier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2009
Achievement of at least very good partial response is a simple and robust prognostic factor in patients with multiple myeloma treated with high-dose therapy: long-term analysis of the IFM 99-02 and 99-04 TrialsJean-Luc Harousseau, Herve Avet-Loiseau, Michel Attal, et al.
Blood|August 10, 1999
Stem cell factor in combination with filgrastim after chemotherapy improves peripheral blood progenitor cell yield and reduces apheresis requirements in multiple myeloma patients: a randomized, controlled trialT Facon, J L Harousseau, F Maloisel, et al.
Neurology|December 9, 2016
Disparities and guideline adherence in drugs of abuse screening in intracerebral hemorrhageLaura M Tormoehlen, Ashley D Blatsioris, Elizabeth A S Moser, et al.
The Journal of Antimicrobial Chemotherapy|August 15, 2019
Durability of antimicrobial activity of antibiotic-impregnated external ventricular drains: a prospective studyRoman Mounier, Elodie Lang, Anne Hulin, et al.
Pageof 138